Douglas L. Braunstein, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), bought 40,800 shares at $48.06 ($2.0M) on 2017-08-09, disclosed to the SEC on 2017-08-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.06 | 3,610 | $173K | 8.7% |
| 2 | $48.06 | 3,610 | $173K | 8.7% |
| 3 | $49.21 | 15,206 | $748K | 37.4% |
| 4 | $49.21 | 15,206 | $748K | 37.4% |
| 5 | $50.09 | 1,584 | $79K | 4.0% |
| 6 | $50.09 | 1,584 |
| $79K |
| 4.0% |
| Total | $49.07 avg | 40,800 | $2.0M | 100% |
| Filing → |
| TALK | BUY | 2021-06-24 | $50.0M | — | Filing → |
| HCII | SELL | 2021-04-14 | $0 | — | Filing → |
| EGRX | SELL | 2019-10-15 | $716K | — | Filing → |